Rapid virus test aims to slash needless antibiotic prescriptions

NCT ID NCT07243249

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a rapid nose swab test that detects three common respiratory viruses (COVID-19, flu, and RSV) can help doctors avoid prescribing antibiotics when they aren't needed. About 2,000 people with respiratory symptoms will be enrolled. Doctors will either prescribe antibiotics as usual or use the test results to guide their decision. The goal is to see if the test reduces unnecessary antibiotic use, which can lead to antibiotic resistance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Triplex rapid diagnostic test (TROD) for SARS-CoV-2, influenza, and RSV
What this could lead to: If successful, this could show that rapid virus testing helps doctors avoid unnecessary antibiotics, reducing antibiotic resistance.
What could go wrong: This is an observational study, not a treatment trial. Results may not change prescribing habits in all settings, and the test may not catch all infections.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIBIOTIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTIBIOTIC RESPIRATORY INFECTIONS

Contacts and locations

Locations

Assistance Publique - Hôpitaux de Paris
RECRUITING

Garches, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.